Cargando…
Analysis of Therapeutic Inertia and Race and Ethnicity in the Systolic Blood Pressure Intervention Trial: A Secondary Analysis of a Randomized Clinical Trial
IMPORTANCE: Therapeutic inertia may contribute to racial and ethnic differences in blood pressure (BP) control. OBJECTIVE: To determine the association between race and ethnicity and therapeutic inertia in the Systolic Blood Pressure Intervention Trial (SPRINT). DESIGN, SETTING, AND PARTICIPANTS: Th...
Autores principales: | Zheutlin, Alexander R., Mondesir, Favel L., Derington, Catherine G., King, Jordan B., Zhang, Chong, Cohen, Jordana B., Berlowitz, Dan R., Anstey, D. Edmund, Cushman, William C., Greene, Tom H., Ogedegbe, Olugbenga, Bress, Adam P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749480/ https://www.ncbi.nlm.nih.gov/pubmed/35006243 http://dx.doi.org/10.1001/jamanetworkopen.2021.43001 |
Ejemplares similares
-
Trends in Hypertension Clinical Trials Focused on Interventions Specific for Black Adults: An Analysis of ClinicalTrials.gov
por: Zheutlin, Alexander R., et al.
Publicado: (2020) -
Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial
por: Still, Carolyn H, et al.
Publicado: (2018) -
New Users of Angiotensin II Receptor Blocker–Versus Angiotensin‐Converting Enzyme Inhibitor–Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD‐BP and SPRINT
por: King, Jordan B., et al.
Publicado: (2023) -
Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT)
por: Cohen, Jordana B., et al.
Publicado: (2022) -
Antihypertensive Medication Regimens Used by US Adults With Hypertension and the Potential for Fixed‐Dose Combination Products: The National Health and Nutrition Examination Surveys 2015 to 2020
por: Derington, Catherine G., et al.
Publicado: (2023)